Martek
This article was originally published in The Tan Sheet
Executive Summary
Company's nutritional oils enriched with docosahexaenoic acid (DHA) and arachidonic acid (ARA) will be sold in term infant formulas in the U.K., Martek Biosciences announces March 6. Wyeth Nutritionals International, a subsidiary of Wyeth-Ayerst Pharmaceuticals, will include ingredients in SMA Gold term infant formula. FDA is reviewing DHA/ARA as ingredients in formulas to be marketed in U.S.; Martek expects a decision within the year. The firm also announces March 2 completion of approximately $20 mil. in financing with investor group, selling over 1.2 mil. shares of its common stock and issuing warrants to purchase 319,811 shares
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning